Data Reported
Data Reported
Height Trial Logo

A Phase 3 clinical trial comparing TransConTM hGH administered once weekly

to a daily growth hormone in children with growth hormone deficiency (GHD).

For more information please visit

  • Clinicaltrials.gov
  • Ascendispharma.com

hGH = human growth hormone.

Ascendis, Ascendis Pharma, Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group © November 2019 Ascendis Pharma A/S. | Privacy Policy